Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

Accumulating evidence demonstrates the decisive role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade in preclinical tumor models, as well as in cancer patients. In synthesis, it appears that a normal int...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Daillère, Romain, Derosa, Lisa, Bonvalet, Mélodie, Segata, Nicola, Routy, Bertrand, Gariboldi, Manuela, Budinská, Eva, De Vries, I. Jolanda M., Naccarati, Alessio Gordon, Zitvogel, Valérie, Caldas, Carlos, Engstrand, Lars, Loilbl, Sibylle, Fieschi, Jacques, Heinzerling, Lucie, Kroemer, Guido, Zitvogel, Laurence
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7466862/
https://ncbi.nlm.nih.gov/pubmed/32934879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1774298
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars